CONMED | CNMD - Debt


CONMED reported $853.75M in Debt for its fiscal quarter ending in September of 2025.





Debt Change Date
3M USD 12.6B 1000K Dec/2025
Abbott USD 12.94B 496M Sep/2025
Accuray USD 170.24M 4.52M Sep/2024
AtriCure USD 76.73M 521K Sep/2025
Avanos Medical USD 133.7M 3.6M Sep/2025
Baxter International USD 9.71B 13M Sep/2025
Becton, Dickinson and Co. USD 19.54B 358M Dec/2025
Boston Scientific USD 12.05B 19M Sep/2025
CONMED USD 853.75M 28.07M Sep/2025
Cooper Companies USD 2.48B 285.1M Jun/2025
Dexcom USD 1.24B 1.21B Dec/2025
Edwards Lifesciences USD 700.3M 2.3M Sep/2025
Globus Medical USD 119.34M 1.76M Sep/2025
Hologic USD 2.63B 104.3M Sep/2025
Inogen USD 0 0 Jun/2022
Insulet USD 1.01B 384.9M Sep/2025
Integra LifeSciences USD 2.01B 170.48M Jun/2025
Intuitive Surgical USD 0 0 Mar/2025
J&J USD 45.8B 4.97B Sep/2025
Masimo USD 642.2M 299.4M Jun/2025
Medtronic USD 29.1B 491M Sep/2025
Merit Medical Systems USD 821.15M 599K Sep/2025
Olympus JPY 233.87B 4.77B Sep/2025
Orthofix International USD 137.23M 338K Sep/2024
ResMed USD 846.35M 178.06M Sep/2025
Smith & Nephew USD 3.32B 334M Dec/2024
Steris USD 2.06B 10.4M Sep/2025
Stryker USD 14.86B 1.74B Dec/2025
Tandem Diabetes Care USD 449.28M 276K Sep/2025
Teleflex USD 2B 180.08M Jun/2025
Zimmer Biomet Holdings USD 7.52B 593.5M Dec/2025